Article
type: Class

Document
type: Class

Academic Article
type: Class

Information Content Entity
type: Class

Continuant
type: Class

Inglese
type: Language

Entity
type: Class

Efficacy and safety of ruxolitinib in intermediate-1 IPSS risk myelofibrosis patients: Results from an independent study
type: Information Content Entity
type: Generically Dependent Continuant
type: Academic Article
type: Continuant
type: Entity
type: Article
type: Document
most specific type: Academic Article
type: Thing
language: Inglese

Generically Dependent Continuant
type: Class

RDF description of Efficacy and safety of ruxolitinib in intermediate-1 IPSS risk myelofibrosis patients: Results from an independent study - http://irises.unibs.it/resource/item/175559
rights: termsOfUse
date: 2026-08-25T22:11:00
publisher: Efficacy and safety of ruxolitinib in intermediate-1 IPSS risk myelofibrosis patients: Results from an independent study
type: Document